Does ALIROCUMAB Cause Injection site rash? 249 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 249 reports of Injection site rash have been filed in association with ALIROCUMAB (Praluent). This represents 1.1% of all adverse event reports for ALIROCUMAB.
249
Reports of Injection site rash with ALIROCUMAB
1.1%
of all ALIROCUMAB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Injection site rash From ALIROCUMAB?
Of the 249 reports, 7 (2.8%) required hospitalization.
Is Injection site rash Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 249 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Injection site rash?
ETANERCEPT (3,781)
DUPILUMAB (3,566)
ADALIMUMAB (2,108)
TIRZEPATIDE (1,131)
IXEKIZUMAB (526)
DULAGLUTIDE (501)
EVOLOCUMAB (465)
TERIPARATIDE (426)
SARILUMAB (424)
HYDROXYPROGESTERONE CAPROATE (384)
Which ALIROCUMAB Alternatives Have Lower Injection site rash Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN